EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 12 (2026) SICOT-J, 12 (2026) E1 References
Open Access
Editorial
Issue
SICOT-J
Volume 12, 2026
Article Number E1
Number of page(s) 7
DOI https://doi.org/10.1051/sicotj/2025067
Published online 06 March 2026
  1. Luo G, Liu H, Lu H (2016) Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients? Br J Clin Pharmacol 81(1), 78–88. [Google Scholar]
  2. Driessen JHM, van Onzenoort HAW, Starup-Linde J, Henry R, Burden AM, Neef C, van den Bergh JP, Vestergaard P, de Vries F (2015) Use of glucagon-like-peptide 1 receptor agonists and risk of fracture as compared to use of other anti-hyperglycemic drugs. Calcif Tissue Int 97(5), 506–515. [Google Scholar]
  3. Wylie E, Clarke S (2023) Key conditions and principles of orthopaedic management. In: Orthopaedic and Trauma Nursing. John Wiley & Sons, Ltd. 157–179. [Google Scholar]
  4. Spence DB, Austin R, Carrol C, Agoritsas T, Guyatt GH, White H, Gao Y, Agarwal A, Macdonald H, Zou X, Millard T, Schnell O, Marx N, Brosius FC 3rd, McDonald S, Quigley M, Tian X, Fan Q, White B, Mao Y, Pan X, Liu C, Zhai C, Yuan C, Li Q, An J, Gan Y, Wang Y, Jin Y, Sun F, Zhu Z, Rydén L, Standl E, Turner T, Vandvik PO, Li S (2024) Glucagon-like peptide-1 receptor agonists for weight loss in orthopaedic surgery: A comprehensive review. JBJS J Orthop Physician Assist 12(3), e24.00005. [Google Scholar]
  5. Wiener JM, Sanghvi PA, Vlastaris K, Mroz T, Belding J, Kaelber DC, Olson T, Francis KP, Adams JS, Bernthal N, Sheppard WL (2025) Glucagon-like peptide-1 receptor agonist medications alter outcomes of spine surgery: A study among over 15,000 patients. Spine 50(13), 871. [Google Scholar]
  6. Carter M, Fisher C, Isaac M (2013) Recovery from comorbidity: Depression or anxiety with alcohol misuse – A systematic and integrative supradisciplinary review and critical appraisal. SAGE Open 3(4), 2158244013512133. [Google Scholar]
  7. Xi H, Pang Z, Liu Y, Xue L, He J, Yang W (2023) Research progress of perioperative application of GLP-1 and its protective effects on organs. J Clin Nurs Res 7(4), 19–28. [Google Scholar]
  8. Anastasilakis AD, Paccou J, Palermo A, Polyzos SA (2025) The effects of anti-obesity medications on bone metabolism: A critical appraisal. Diabetes Obes Metab 27(9), 4674–4688. [Google Scholar]
  9. Jensen JE, Jensen TG, Smith TK, Johnston DA, Dudrick SJ (1982) Nutrition in orthopaedic surgery. JBJS 64(9), 1263. [Google Scholar]
  10. Custodio-Lumsden CL, Everett S (2014) Perioperative nutrition in the orthopedic surgical patient. In: Perioperative Care of the Orthopedic Patient. MacKenzie CR, Cornell CN, Memtsoudis SG, Editors. Springer. 239–257. [Google Scholar]
  11. Arsakhanova G, Odarchenko D, Khamchiev K (2024) The environmental impact of health care: Environmental sustainability in orthopaedic surgery. BIO Web Conf 140, 05006. [Google Scholar]
  12. Engler ID, Curley AJ (2022) Environmental sustainability in orthopaedic surgery – Where we are and where we are going. Oper Tech Orthop 32(4), 100995. [Google Scholar]
  13. Abdulrazeq H, Taman M, Ali R, Doberstein C, Sullivan P, Sampath P, Telfeian A, Gokaslan Z, Fridley J, Asaad W (2024) GLP-1 receptor agonists: Beyond diabetes – What the neurosurgeon needs to know. Neurosurg Pract 5(3), e00098. [Google Scholar]
  14. Lefine ML, Lesunyane RA (2023) Enablers and inhibitors to quality of life as experienced by substance abusers discharged from a rehabilitation centre in Gauteng, South Africa. South Afr J Occup Ther 52(3), 62–72. [Google Scholar]
  15. Laudet AB, Morgen K, White WL (2006) The role of social supports, spirituality, religiousness, life meaning and affiliation with 12-step fellowships in quality of life satisfaction among individuals in recovery from alcohol and drug problems. Alcohol Treat Q 24(1–2), 33–73. [Google Scholar]
  16. Mabilleau G (2015) Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures? Endocrine 48(1), 1–2. [Google Scholar]
  17. Aljuhani W, Sayyad Y (2024) Orthopedic research funding: Assessing the relationship between investments and breakthroughs. Orthop Rev 16, 120368. [Google Scholar]
  18. Meurot C, Jacques C, Martin C, Sudre L, Breton J, Rattenbach R, Bismuth K, Berenbaum F (2022) Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? J Orthop Transl 32, 121–129. [Google Scholar]
  19. Nance MA (2014) Comprehensive care. In: Huntington’s Disease. Bates G, Tabrizi S, Jones L, Editors. Oxford University Press. [Google Scholar]
  20. Han Y, Li Y, He B (2019) GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod Biomed Online 39(2), 332–342. [Google Scholar]
  21. Magaldi RJ, Strecker SE, Witmer D (2024) Glucagon-like peptide-1 agonists in total hip arthroplasty: Complications, readmissions, and patient-reported outcomes. JAAOS Glob Res Rev 8(11), e24.00148. [Google Scholar]
  22. Abouzid M, Al-Ajlouni YA, Abuelazm M, Altobaishat O, Manasrah A, Turkmani M, Khan U, Abouzid M (2024) The efficacy and safety of GLP-1 agonists to modify cardiovascular morbidity in patients with obesity without diabetes mellitus: a meta-analysis involving 32, 884 patients. Eur Heart J 45(Supplement_1), ehae666.3279. [Google Scholar]
  23. Baig MU, Piazza A, Lahooti A, Johnson KE, Rangwani S, Gouda Z, Mahadev S, Newberry C, Hanscom M, Sampath K, Kumar S, Anca D, Schulman AR, Carr-Locke DL, Sharaiha RZ (2025) Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis. Gastrointest Endosc 101(4), 762–771.e13. [Google Scholar]
  24. Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, Jones KL, Wu T, Horowitz M, Nauck MA (2024) Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. J Clin Endocrinol Metab 110(1), 1–15. Erratum in: J Clin Endocrinol Metab. 2025 110(10), e3556. [Google Scholar]
  25. Joshi GP, Abdelmalak BB, Weigel WA, Harbell MW, Kuo CI, Soriano SG, Stricker PA, Tipton T, Grant MD, Marbella AM, Agarkar M, Blanck JF, Domino KB (2023) 2023 American society of anesthesiologists practice guidelines for preoperative fasting: Carbohydrate-containing clear liquids with or without protein, chewing gum, and pediatric fasting duration-A modular update of the 2017 American society of anesthesiologists practice guidelines for preoperative fasting. Anesthesiology 138(2), 132–151. [Google Scholar]
  26. Hocking SL, Scott DA, Remedios ML, Horowitz M, Story DA, Greenfield JR, Boussioutas A, Devereaux B, Andrikopoulos S, Shaw JE, Olesnicky BL (2025) 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists. Anaesth Intensive Care 53(5), 300–306. [Google Scholar]
  27. Kindel TL, Wang AY, Wadhwa A, Schulman AR, Sharaiha RZ, Kroh M, Ghanem OM, Levy S, Joshi GP, LaMasters TL; American Gastroenterological Association; American Society for Metabolic and Bariatric Surgery; American Society of Anesthesiologists; International Society of Perioperative Care of Patients with Obesity; Society of American Gastrointestinal and Endoscopic Surgeons (2025) Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Clin Gastroenterol Hepatol 23(12), 2083–2085. [Google Scholar]
  28. Lee A, Kuo B (2010) Metoclopramide in the treatment of diabetic gastroparesis. Expert Rev Endocrinol Metab 5(5), 653–662. [Google Scholar]
  29. Casey DE (2003) Long-term treatment goals: Enhancing healthy outcomes. CNS Spectr 8(S2), 26–28. [Google Scholar]
  30. Kaneko S, Ueda Y, Tahara Y (2018) GLP1 receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in type 2 diabetes within enhanced recovery after surgery (ERAS) protocols. Eur Surg Res 59(5–6), 349–360. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.